nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Levorphanol—Estradiol—osteoporosis	0.509	1	CrCrCtD
Hydrocodone—CYP3A4—Estropipate—osteoporosis	0.0408	0.158	CbGbCtD
Hydrocodone—CYP3A4—Calcitriol—osteoporosis	0.0408	0.158	CbGbCtD
Hydrocodone—CYP2D6—Cholecalciferol—osteoporosis	0.033	0.128	CbGbCtD
Hydrocodone—CYP3A4—Ergocalciferol—osteoporosis	0.0326	0.126	CbGbCtD
Hydrocodone—CYP3A4—Raloxifene—osteoporosis	0.0272	0.105	CbGbCtD
Hydrocodone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0263	0.102	CbGbCtD
Hydrocodone—CYP3A4—Cholecalciferol—osteoporosis	0.021	0.0814	CbGbCtD
Hydrocodone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0193	0.0748	CbGbCtD
Hydrocodone—CYP3A4—Estradiol—osteoporosis	0.0169	0.0656	CbGbCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000412	0.00178	CcSEcCtD
Hydrocodone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000412	0.00178	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000411	0.00178	CcSEcCtD
Hydrocodone—Somnolence—Calcitriol—osteoporosis	0.00041	0.00177	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000407	0.00176	CcSEcCtD
Hydrocodone—Fatigue—Ibandronate—osteoporosis	0.000406	0.00176	CcSEcCtD
Hydrocodone—Arthralgia—Risedronate—osteoporosis	0.000405	0.00175	CcSEcCtD
Hydrocodone—Myalgia—Risedronate—osteoporosis	0.000405	0.00175	CcSEcCtD
Hydrocodone—Anxiety—Risedronate—osteoporosis	0.000404	0.00175	CcSEcCtD
Hydrocodone—Constipation—Ibandronate—osteoporosis	0.000403	0.00174	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000402	0.00174	CcSEcCtD
Hydrocodone—Pruritus—Etidronic acid—osteoporosis	0.000402	0.00174	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Estropipate—osteoporosis	0.000402	0.00174	CcSEcCtD
Hydrocodone—Mental disorder—Conjugated Estrogens—osteoporosis	0.0004	0.00173	CcSEcCtD
Hydrocodone—Back pain—Zoledronate—osteoporosis	0.0004	0.00173	CcSEcCtD
Hydrocodone—Malnutrition—Conjugated Estrogens—osteoporosis	0.000398	0.00172	CcSEcCtD
Hydrocodone—Muscle spasms—Zoledronate—osteoporosis	0.000397	0.00172	CcSEcCtD
Hydrocodone—Dry mouth—Risedronate—osteoporosis	0.000396	0.00171	CcSEcCtD
Hydrocodone—Urinary tract infection—Estradiol—osteoporosis	0.000396	0.00171	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Alendronate—osteoporosis	0.000396	0.00171	CcSEcCtD
Hydrocodone—Cough—Pamidronate—osteoporosis	0.000395	0.00171	CcSEcCtD
Hydrocodone—Constipation—Calcitriol—osteoporosis	0.000394	0.00171	CcSEcCtD
Hydrocodone—Convulsion—Pamidronate—osteoporosis	0.000392	0.00169	CcSEcCtD
Hydrocodone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00039	0.00169	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Raloxifene—osteoporosis	0.000389	0.00168	CcSEcCtD
Hydrocodone—Abdominal pain—Estropipate—osteoporosis	0.000388	0.00168	CcSEcCtD
Hydrocodone—Body temperature increased—Estropipate—osteoporosis	0.000388	0.00168	CcSEcCtD
Hydrocodone—Tremor—Zoledronate—osteoporosis	0.000387	0.00167	CcSEcCtD
Hydrocodone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000387	0.00167	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Ibandronate—osteoporosis	0.000385	0.00167	CcSEcCtD
Hydrocodone—Myalgia—Pamidronate—osteoporosis	0.000385	0.00167	CcSEcCtD
Hydrocodone—Arthralgia—Pamidronate—osteoporosis	0.000385	0.00167	CcSEcCtD
Hydrocodone—Back pain—Conjugated Estrogens—osteoporosis	0.000385	0.00166	CcSEcCtD
Hydrocodone—Anxiety—Pamidronate—osteoporosis	0.000384	0.00166	CcSEcCtD
Hydrocodone—Body temperature increased—Alendronate—osteoporosis	0.000382	0.00165	CcSEcCtD
Hydrocodone—Abdominal pain—Alendronate—osteoporosis	0.000382	0.00165	CcSEcCtD
Hydrocodone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000382	0.00165	CcSEcCtD
Hydrocodone—Nervous system disorder—Risedronate—osteoporosis	0.000381	0.00165	CcSEcCtD
Hydrocodone—Skin disorder—Risedronate—osteoporosis	0.000377	0.00163	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000377	0.00163	CcSEcCtD
Hydrocodone—Abdominal pain—Raloxifene—osteoporosis	0.000376	0.00163	CcSEcCtD
Hydrocodone—Body temperature increased—Raloxifene—osteoporosis	0.000376	0.00163	CcSEcCtD
Hydrocodone—Abdominal pain—Ibandronate—osteoporosis	0.000372	0.00161	CcSEcCtD
Hydrocodone—Body temperature increased—Ibandronate—osteoporosis	0.000372	0.00161	CcSEcCtD
Hydrocodone—Abdominal pain—Calcitriol—osteoporosis	0.000365	0.00158	CcSEcCtD
Hydrocodone—Body temperature increased—Calcitriol—osteoporosis	0.000365	0.00158	CcSEcCtD
Hydrocodone—Hypersensitivity—Estropipate—osteoporosis	0.000362	0.00157	CcSEcCtD
Hydrocodone—Nervous system disorder—Pamidronate—osteoporosis	0.000362	0.00157	CcSEcCtD
Hydrocodone—Thrombocytopenia—Pamidronate—osteoporosis	0.000361	0.00156	CcSEcCtD
Hydrocodone—Vomiting—Etidronic acid—osteoporosis	0.000361	0.00156	CcSEcCtD
Hydrocodone—Cough—Zoledronate—osteoporosis	0.00036	0.00156	CcSEcCtD
Hydrocodone—Oedema peripheral—Estradiol—osteoporosis	0.00036	0.00156	CcSEcCtD
Hydrocodone—Connective tissue disorder—Estradiol—osteoporosis	0.000359	0.00155	CcSEcCtD
Hydrocodone—Rash—Etidronic acid—osteoporosis	0.000358	0.00155	CcSEcCtD
Hydrocodone—Convulsion—Zoledronate—osteoporosis	0.000358	0.00155	CcSEcCtD
Hydrocodone—Dermatitis—Etidronic acid—osteoporosis	0.000358	0.00155	CcSEcCtD
Hydrocodone—Hyperhidrosis—Pamidronate—osteoporosis	0.000357	0.00154	CcSEcCtD
Hydrocodone—Hypersensitivity—Alendronate—osteoporosis	0.000356	0.00154	CcSEcCtD
Hydrocodone—Headache—Etidronic acid—osteoporosis	0.000356	0.00154	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000354	0.00153	CcSEcCtD
Hydrocodone—Asthenia—Estropipate—osteoporosis	0.000352	0.00152	CcSEcCtD
Hydrocodone—Arthralgia—Zoledronate—osteoporosis	0.000352	0.00152	CcSEcCtD
Hydrocodone—Myalgia—Zoledronate—osteoporosis	0.000352	0.00152	CcSEcCtD
Hydrocodone—Insomnia—Risedronate—osteoporosis	0.000351	0.00152	CcSEcCtD
Hydrocodone—Anxiety—Zoledronate—osteoporosis	0.00035	0.00152	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000349	0.00151	CcSEcCtD
Hydrocodone—Paraesthesia—Risedronate—osteoporosis	0.000349	0.00151	CcSEcCtD
Hydrocodone—Pruritus—Estropipate—osteoporosis	0.000348	0.0015	CcSEcCtD
Hydrocodone—Asthenia—Alendronate—osteoporosis	0.000347	0.0015	CcSEcCtD
Hydrocodone—Hypersensitivity—Ibandronate—osteoporosis	0.000347	0.0015	CcSEcCtD
Hydrocodone—Cough—Conjugated Estrogens—osteoporosis	0.000347	0.0015	CcSEcCtD
Hydrocodone—Dyspnoea—Risedronate—osteoporosis	0.000346	0.0015	CcSEcCtD
Hydrocodone—Hypotension—Pamidronate—osteoporosis	0.000345	0.00149	CcSEcCtD
Hydrocodone—Convulsion—Conjugated Estrogens—osteoporosis	0.000345	0.00149	CcSEcCtD
Hydrocodone—Dry mouth—Zoledronate—osteoporosis	0.000344	0.00149	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000344	0.00149	CcSEcCtD
Hydrocodone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000343	0.00148	CcSEcCtD
Hydrocodone—Pruritus—Alendronate—osteoporosis	0.000342	0.00148	CcSEcCtD
Hydrocodone—Constipation—Ethinyl Estradiol—osteoporosis	0.00034	0.00147	CcSEcCtD
Hydrocodone—Hypersensitivity—Calcitriol—osteoporosis	0.00034	0.00147	CcSEcCtD
Hydrocodone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000339	0.00146	CcSEcCtD
Hydrocodone—Myalgia—Conjugated Estrogens—osteoporosis	0.000339	0.00146	CcSEcCtD
Hydrocodone—Asthenia—Ibandronate—osteoporosis	0.000338	0.00146	CcSEcCtD
Hydrocodone—Anxiety—Conjugated Estrogens—osteoporosis	0.000337	0.00146	CcSEcCtD
Hydrocodone—Nausea—Etidronic acid—osteoporosis	0.000337	0.00146	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000336	0.00145	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000336	0.00145	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000335	0.00145	CcSEcCtD
Hydrocodone—Fatigue—Risedronate—osteoporosis	0.000335	0.00145	CcSEcCtD
Hydrocodone—Insomnia—Pamidronate—osteoporosis	0.000334	0.00144	CcSEcCtD
Hydrocodone—Pruritus—Ibandronate—osteoporosis	0.000333	0.00144	CcSEcCtD
Hydrocodone—Constipation—Risedronate—osteoporosis	0.000332	0.00144	CcSEcCtD
Hydrocodone—Angiopathy—Estradiol—osteoporosis	0.000332	0.00143	CcSEcCtD
Hydrocodone—Paraesthesia—Pamidronate—osteoporosis	0.000331	0.00143	CcSEcCtD
Hydrocodone—Asthenia—Calcitriol—osteoporosis	0.000331	0.00143	CcSEcCtD
Hydrocodone—Nervous system disorder—Zoledronate—osteoporosis	0.000331	0.00143	CcSEcCtD
Hydrocodone—Thrombocytopenia—Zoledronate—osteoporosis	0.00033	0.00143	CcSEcCtD
Hydrocodone—Mediastinal disorder—Estradiol—osteoporosis	0.00033	0.00143	CcSEcCtD
Hydrocodone—Dyspnoea—Pamidronate—osteoporosis	0.000329	0.00142	CcSEcCtD
Hydrocodone—Somnolence—Pamidronate—osteoporosis	0.000328	0.00142	CcSEcCtD
Hydrocodone—Skin disorder—Zoledronate—osteoporosis	0.000327	0.00142	CcSEcCtD
Hydrocodone—Pruritus—Calcitriol—osteoporosis	0.000326	0.00141	CcSEcCtD
Hydrocodone—Hyperhidrosis—Zoledronate—osteoporosis	0.000326	0.00141	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000326	0.00141	CcSEcCtD
Hydrocodone—Dizziness—Estropipate—osteoporosis	0.000325	0.0014	CcSEcCtD
Hydrocodone—Mental disorder—Estradiol—osteoporosis	0.00032	0.00139	CcSEcCtD
Hydrocodone—Dizziness—Alendronate—osteoporosis	0.00032	0.00138	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000319	0.00138	CcSEcCtD
Hydrocodone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000318	0.00138	CcSEcCtD
Hydrocodone—Malnutrition—Estradiol—osteoporosis	0.000318	0.00138	CcSEcCtD
Hydrocodone—Fatigue—Pamidronate—osteoporosis	0.000318	0.00138	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Risedronate—osteoporosis	0.000317	0.00137	CcSEcCtD
Hydrocodone—Constipation—Pamidronate—osteoporosis	0.000316	0.00136	CcSEcCtD
Hydrocodone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000315	0.00136	CcSEcCtD
Hydrocodone—Hypotension—Zoledronate—osteoporosis	0.000315	0.00136	CcSEcCtD
Hydrocodone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000315	0.00136	CcSEcCtD
Hydrocodone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000315	0.00136	CcSEcCtD
Hydrocodone—Dizziness—Raloxifene—osteoporosis	0.000315	0.00136	CcSEcCtD
Hydrocodone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000314	0.00136	CcSEcCtD
Hydrocodone—Vomiting—Estropipate—osteoporosis	0.000312	0.00135	CcSEcCtD
Hydrocodone—Dizziness—Ibandronate—osteoporosis	0.000311	0.00135	CcSEcCtD
Hydrocodone—Rash—Estropipate—osteoporosis	0.00031	0.00134	CcSEcCtD
Hydrocodone—Dermatitis—Estropipate—osteoporosis	0.000309	0.00134	CcSEcCtD
Hydrocodone—Back pain—Estradiol—osteoporosis	0.000308	0.00133	CcSEcCtD
Hydrocodone—Headache—Estropipate—osteoporosis	0.000308	0.00133	CcSEcCtD
Hydrocodone—Vomiting—Alendronate—osteoporosis	0.000308	0.00133	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000307	0.00133	CcSEcCtD
Hydrocodone—Abdominal pain—Risedronate—osteoporosis	0.000307	0.00133	CcSEcCtD
Hydrocodone—Body temperature increased—Risedronate—osteoporosis	0.000307	0.00133	CcSEcCtD
Hydrocodone—Muscle spasms—Estradiol—osteoporosis	0.000306	0.00132	CcSEcCtD
Hydrocodone—Rash—Alendronate—osteoporosis	0.000305	0.00132	CcSEcCtD
Hydrocodone—Insomnia—Zoledronate—osteoporosis	0.000305	0.00132	CcSEcCtD
Hydrocodone—Dermatitis—Alendronate—osteoporosis	0.000305	0.00132	CcSEcCtD
Hydrocodone—Hypotension—Conjugated Estrogens—osteoporosis	0.000303	0.00131	CcSEcCtD
Hydrocodone—Headache—Alendronate—osteoporosis	0.000303	0.00131	CcSEcCtD
Hydrocodone—Paraesthesia—Zoledronate—osteoporosis	0.000303	0.00131	CcSEcCtD
Hydrocodone—Vomiting—Raloxifene—osteoporosis	0.000303	0.00131	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000302	0.00131	CcSEcCtD
Hydrocodone—Dyspnoea—Zoledronate—osteoporosis	0.000301	0.0013	CcSEcCtD
Hydrocodone—Rash—Raloxifene—osteoporosis	0.0003	0.0013	CcSEcCtD
Hydrocodone—Dermatitis—Raloxifene—osteoporosis	0.0003	0.0013	CcSEcCtD
Hydrocodone—Somnolence—Zoledronate—osteoporosis	0.0003	0.0013	CcSEcCtD
Hydrocodone—Vomiting—Ibandronate—osteoporosis	0.000299	0.0013	CcSEcCtD
Hydrocodone—Tremor—Estradiol—osteoporosis	0.000298	0.00129	CcSEcCtD
Hydrocodone—Headache—Raloxifene—osteoporosis	0.000298	0.00129	CcSEcCtD
Hydrocodone—Rash—Ibandronate—osteoporosis	0.000297	0.00128	CcSEcCtD
Hydrocodone—Dermatitis—Ibandronate—osteoporosis	0.000297	0.00128	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000296	0.00128	CcSEcCtD
Hydrocodone—Headache—Ibandronate—osteoporosis	0.000295	0.00128	CcSEcCtD
Hydrocodone—Insomnia—Conjugated Estrogens—osteoporosis	0.000294	0.00127	CcSEcCtD
Hydrocodone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000293	0.00127	CcSEcCtD
Hydrocodone—Vomiting—Calcitriol—osteoporosis	0.000293	0.00127	CcSEcCtD
Hydrocodone—Nausea—Estropipate—osteoporosis	0.000292	0.00126	CcSEcCtD
Hydrocodone—Abdominal pain—Pamidronate—osteoporosis	0.000292	0.00126	CcSEcCtD
Hydrocodone—Body temperature increased—Pamidronate—osteoporosis	0.000292	0.00126	CcSEcCtD
Hydrocodone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000291	0.00126	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000291	0.00126	CcSEcCtD
Hydrocodone—Rash—Calcitriol—osteoporosis	0.000291	0.00126	CcSEcCtD
Hydrocodone—Fatigue—Zoledronate—osteoporosis	0.000291	0.00126	CcSEcCtD
Hydrocodone—Dermatitis—Calcitriol—osteoporosis	0.00029	0.00126	CcSEcCtD
Hydrocodone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000289	0.00125	CcSEcCtD
Hydrocodone—Headache—Calcitriol—osteoporosis	0.000289	0.00125	CcSEcCtD
Hydrocodone—Somnolence—Conjugated Estrogens—osteoporosis	0.000289	0.00125	CcSEcCtD
Hydrocodone—Constipation—Zoledronate—osteoporosis	0.000288	0.00125	CcSEcCtD
Hydrocodone—Nausea—Alendronate—osteoporosis	0.000287	0.00124	CcSEcCtD
Hydrocodone—Hypersensitivity—Risedronate—osteoporosis	0.000286	0.00124	CcSEcCtD
Hydrocodone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000286	0.00124	CcSEcCtD
Hydrocodone—Nausea—Raloxifene—osteoporosis	0.000283	0.00122	CcSEcCtD
Hydrocodone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000282	0.00122	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00028	0.00121	CcSEcCtD
Hydrocodone—Fatigue—Conjugated Estrogens—osteoporosis	0.00028	0.00121	CcSEcCtD
Hydrocodone—Nausea—Ibandronate—osteoporosis	0.00028	0.00121	CcSEcCtD
Hydrocodone—Asthenia—Risedronate—osteoporosis	0.000279	0.0012	CcSEcCtD
Hydrocodone—Cough—Estradiol—osteoporosis	0.000278	0.0012	CcSEcCtD
Hydrocodone—Constipation—Conjugated Estrogens—osteoporosis	0.000278	0.0012	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000276	0.00119	CcSEcCtD
Hydrocodone—Pruritus—Risedronate—osteoporosis	0.000275	0.00119	CcSEcCtD
Hydrocodone—Nausea—Calcitriol—osteoporosis	0.000274	0.00118	CcSEcCtD
Hydrocodone—Hypersensitivity—Pamidronate—osteoporosis	0.000272	0.00118	CcSEcCtD
Hydrocodone—Arthralgia—Estradiol—osteoporosis	0.000271	0.00117	CcSEcCtD
Hydrocodone—Myalgia—Estradiol—osteoporosis	0.000271	0.00117	CcSEcCtD
Hydrocodone—Anxiety—Estradiol—osteoporosis	0.00027	0.00117	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000269	0.00116	CcSEcCtD
Hydrocodone—Abdominal pain—Zoledronate—osteoporosis	0.000266	0.00115	CcSEcCtD
Hydrocodone—Body temperature increased—Zoledronate—osteoporosis	0.000266	0.00115	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000265	0.00115	CcSEcCtD
Hydrocodone—Dry mouth—Estradiol—osteoporosis	0.000265	0.00115	CcSEcCtD
Hydrocodone—Asthenia—Pamidronate—osteoporosis	0.000265	0.00115	CcSEcCtD
Hydrocodone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000263	0.00114	CcSEcCtD
Hydrocodone—Pruritus—Pamidronate—osteoporosis	0.000261	0.00113	CcSEcCtD
Hydrocodone—Dizziness—Risedronate—osteoporosis	0.000257	0.00111	CcSEcCtD
Hydrocodone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000257	0.00111	CcSEcCtD
Hydrocodone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000257	0.00111	CcSEcCtD
Hydrocodone—Nervous system disorder—Estradiol—osteoporosis	0.000255	0.0011	CcSEcCtD
Hydrocodone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000253	0.00109	CcSEcCtD
Hydrocodone—Skin disorder—Estradiol—osteoporosis	0.000252	0.00109	CcSEcCtD
Hydrocodone—Hyperhidrosis—Estradiol—osteoporosis	0.000251	0.00109	CcSEcCtD
Hydrocodone—Rash—Ethinyl Estradiol—osteoporosis	0.000251	0.00109	CcSEcCtD
Hydrocodone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000251	0.00108	CcSEcCtD
Hydrocodone—Headache—Ethinyl Estradiol—osteoporosis	0.000249	0.00108	CcSEcCtD
Hydrocodone—Hypersensitivity—Zoledronate—osteoporosis	0.000248	0.00107	CcSEcCtD
Hydrocodone—Vomiting—Risedronate—osteoporosis	0.000247	0.00107	CcSEcCtD
Hydrocodone—Rash—Risedronate—osteoporosis	0.000245	0.00106	CcSEcCtD
Hydrocodone—Dermatitis—Risedronate—osteoporosis	0.000245	0.00106	CcSEcCtD
Hydrocodone—Dizziness—Pamidronate—osteoporosis	0.000244	0.00106	CcSEcCtD
Hydrocodone—Headache—Risedronate—osteoporosis	0.000243	0.00105	CcSEcCtD
Hydrocodone—Asthenia—Zoledronate—osteoporosis	0.000242	0.00105	CcSEcCtD
Hydrocodone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000239	0.00103	CcSEcCtD
Hydrocodone—Pruritus—Zoledronate—osteoporosis	0.000238	0.00103	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000237	0.00102	CcSEcCtD
Hydrocodone—Nausea—Ethinyl Estradiol—osteoporosis	0.000236	0.00102	CcSEcCtD
Hydrocodone—Insomnia—Estradiol—osteoporosis	0.000235	0.00102	CcSEcCtD
Hydrocodone—Vomiting—Pamidronate—osteoporosis	0.000235	0.00101	CcSEcCtD
Hydrocodone—Paraesthesia—Estradiol—osteoporosis	0.000233	0.00101	CcSEcCtD
Hydrocodone—Asthenia—Conjugated Estrogens—osteoporosis	0.000233	0.00101	CcSEcCtD
Hydrocodone—Rash—Pamidronate—osteoporosis	0.000233	0.00101	CcSEcCtD
Hydrocodone—Dermatitis—Pamidronate—osteoporosis	0.000232	0.00101	CcSEcCtD
Hydrocodone—Dyspnoea—Estradiol—osteoporosis	0.000232	0.001	CcSEcCtD
Hydrocodone—Headache—Pamidronate—osteoporosis	0.000231	0.001	CcSEcCtD
Hydrocodone—Somnolence—Estradiol—osteoporosis	0.000231	0.000999	CcSEcCtD
Hydrocodone—Nausea—Risedronate—osteoporosis	0.000231	0.000997	CcSEcCtD
Hydrocodone—Pruritus—Conjugated Estrogens—osteoporosis	0.00023	0.000993	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000224	0.00097	CcSEcCtD
Hydrocodone—Fatigue—Estradiol—osteoporosis	0.000224	0.000969	CcSEcCtD
Hydrocodone—Dizziness—Zoledronate—osteoporosis	0.000223	0.000964	CcSEcCtD
Hydrocodone—Constipation—Estradiol—osteoporosis	0.000222	0.000961	CcSEcCtD
Hydrocodone—Nausea—Pamidronate—osteoporosis	0.000219	0.000948	CcSEcCtD
Hydrocodone—Dizziness—Conjugated Estrogens—osteoporosis	0.000215	0.000928	CcSEcCtD
Hydrocodone—Vomiting—Zoledronate—osteoporosis	0.000214	0.000927	CcSEcCtD
Hydrocodone—Rash—Zoledronate—osteoporosis	0.000213	0.000919	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Estradiol—osteoporosis	0.000212	0.000919	CcSEcCtD
Hydrocodone—Dermatitis—Zoledronate—osteoporosis	0.000212	0.000918	CcSEcCtD
Hydrocodone—Headache—Zoledronate—osteoporosis	0.000211	0.000913	CcSEcCtD
Hydrocodone—Vomiting—Conjugated Estrogens—osteoporosis	0.000206	0.000893	CcSEcCtD
Hydrocodone—Abdominal pain—Estradiol—osteoporosis	0.000205	0.000888	CcSEcCtD
Hydrocodone—Body temperature increased—Estradiol—osteoporosis	0.000205	0.000888	CcSEcCtD
Hydrocodone—Rash—Conjugated Estrogens—osteoporosis	0.000205	0.000885	CcSEcCtD
Hydrocodone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000204	0.000884	CcSEcCtD
Hydrocodone—Headache—Conjugated Estrogens—osteoporosis	0.000203	0.000879	CcSEcCtD
Hydrocodone—Nausea—Zoledronate—osteoporosis	0.0002	0.000866	CcSEcCtD
Hydrocodone—Nausea—Conjugated Estrogens—osteoporosis	0.000193	0.000834	CcSEcCtD
Hydrocodone—Hypersensitivity—Estradiol—osteoporosis	0.000191	0.000828	CcSEcCtD
Hydrocodone—Asthenia—Estradiol—osteoporosis	0.000186	0.000806	CcSEcCtD
Hydrocodone—Pruritus—Estradiol—osteoporosis	0.000184	0.000795	CcSEcCtD
Hydrocodone—Dizziness—Estradiol—osteoporosis	0.000172	0.000743	CcSEcCtD
Hydrocodone—Vomiting—Estradiol—osteoporosis	0.000165	0.000714	CcSEcCtD
Hydrocodone—Rash—Estradiol—osteoporosis	0.000164	0.000708	CcSEcCtD
Hydrocodone—Dermatitis—Estradiol—osteoporosis	0.000164	0.000708	CcSEcCtD
Hydrocodone—Headache—Estradiol—osteoporosis	0.000163	0.000704	CcSEcCtD
Hydrocodone—Nausea—Estradiol—osteoporosis	0.000154	0.000667	CcSEcCtD
Hydrocodone—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	9.58e-06	0.00548	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.47e-06	0.00542	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—PTHLH—osteoporosis	9.45e-06	0.0054	CbGpPWpGaD
Hydrocodone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	9.45e-06	0.0054	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	9.45e-06	0.0054	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—WNT1—osteoporosis	9.17e-06	0.00524	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PTH1R—osteoporosis	9.1e-06	0.0052	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CALCR—osteoporosis	9.1e-06	0.0052	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MGLL—osteoporosis	8.85e-06	0.00506	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—ADCY5—osteoporosis	8.57e-06	0.0049	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—MGLL—osteoporosis	8.55e-06	0.00489	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—POMC—osteoporosis	8.52e-06	0.00487	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL1B—osteoporosis	8.52e-06	0.00487	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—PTH—osteoporosis	8.45e-06	0.00483	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CALCA—osteoporosis	8.32e-06	0.00476	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—PTHLH—osteoporosis	8.29e-06	0.00474	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PTH1R—osteoporosis	8.26e-06	0.00472	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CALCR—osteoporosis	8.26e-06	0.00472	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CNR2—osteoporosis	8.24e-06	0.00471	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MGLL—osteoporosis	7.76e-06	0.00444	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—WNT1—osteoporosis	7.75e-06	0.00443	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.64e-06	0.00437	CbGpPWpGaD
Hydrocodone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.54e-06	0.00431	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—POMC—osteoporosis	7.47e-06	0.00427	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CALCA—osteoporosis	7.3e-06	0.00417	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SOST—osteoporosis	7.28e-06	0.00416	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—ADCY5—osteoporosis	7.25e-06	0.00414	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—MGLL—osteoporosis	7.23e-06	0.00413	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—POMC—osteoporosis	7.19e-06	0.00411	CbGpPWpGaD
Hydrocodone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.02e-06	0.00402	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—PTHLH—osteoporosis	7.01e-06	0.00401	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—TGFB1—osteoporosis	6.62e-06	0.00379	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CALCR—osteoporosis	6.58e-06	0.00376	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTH1R—osteoporosis	6.58e-06	0.00376	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MGLL—osteoporosis	6.56e-06	0.00375	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PTH—osteoporosis	6.45e-06	0.00369	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SOST—osteoporosis	6.38e-06	0.00365	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—POMC—osteoporosis	6.32e-06	0.00361	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—POMC—osteoporosis	6.31e-06	0.00361	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CNR2—osteoporosis	6.28e-06	0.00359	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.26e-06	0.00358	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.19e-06	0.00354	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6.18e-06	0.00353	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CALCA—osteoporosis	6.17e-06	0.00353	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PTH—osteoporosis	5.85e-06	0.00335	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CALCR—osteoporosis	5.77e-06	0.0033	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTH1R—osteoporosis	5.77e-06	0.0033	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.72e-06	0.00327	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CNR2—osteoporosis	5.71e-06	0.00326	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.69e-06	0.00325	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PTH—osteoporosis	5.65e-06	0.00323	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CNR2—osteoporosis	5.51e-06	0.00315	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SOST—osteoporosis	5.4e-06	0.00308	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—WNT1—osteoporosis	5.36e-06	0.00307	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PTHLH—osteoporosis	5.34e-06	0.00305	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	5.33e-06	0.00305	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MGLL—osteoporosis	5.23e-06	0.00299	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PTH—osteoporosis	5.13e-06	0.00294	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LRP5—osteoporosis	5.1e-06	0.00292	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.03e-06	0.00288	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.01e-06	0.00287	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CNR2—osteoporosis	5e-06	0.00286	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	4.99e-06	0.00285	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	4.96e-06	0.00284	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LRP6—osteoporosis	4.88e-06	0.00279	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CALCR—osteoporosis	4.88e-06	0.00279	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTH1R—osteoporosis	4.88e-06	0.00279	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PTHLH—osteoporosis	4.85e-06	0.00277	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PTH—osteoporosis	4.78e-06	0.00273	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—WNT1—osteoporosis	4.7e-06	0.00269	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CALCA—osteoporosis	4.7e-06	0.00269	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PTHLH—osteoporosis	4.68e-06	0.00268	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	4.66e-06	0.00266	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.59e-06	0.00263	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MGLL—osteoporosis	4.59e-06	0.00262	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LRP5—osteoporosis	4.48e-06	0.00256	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—POMC—osteoporosis	4.35e-06	0.00249	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PTH—osteoporosis	4.34e-06	0.00248	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LRP6—osteoporosis	4.28e-06	0.00245	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CALCA—osteoporosis	4.27e-06	0.00244	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PTHLH—osteoporosis	4.25e-06	0.00243	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.24e-06	0.00242	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CNR2—osteoporosis	4.23e-06	0.00242	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CALCA—osteoporosis	4.12e-06	0.00236	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TLN1—osteoporosis	4.12e-06	0.00236	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—WNT1—osteoporosis	3.98e-06	0.00227	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	3.96e-06	0.00226	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MGLL—osteoporosis	3.88e-06	0.00222	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—POMC—osteoporosis	3.82e-06	0.00218	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LRP5—osteoporosis	3.78e-06	0.00216	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CALCA—osteoporosis	3.75e-06	0.00214	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.72e-06	0.00213	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LRP6—osteoporosis	3.62e-06	0.00207	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TLN1—osteoporosis	3.62e-06	0.00207	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	3.6e-06	0.00206	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—P4HB—osteoporosis	3.56e-06	0.00203	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	3.49e-06	0.00199	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTH—osteoporosis	3.46e-06	0.00198	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAP1A—osteoporosis	3.4e-06	0.00194	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CNR2—osteoporosis	3.37e-06	0.00193	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADCY5—osteoporosis	3.35e-06	0.00191	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFATC1—osteoporosis	3.32e-06	0.0019	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.29e-06	0.00188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DKK1—osteoporosis	3.29e-06	0.00188	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.24e-06	0.00186	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—POMC—osteoporosis	3.23e-06	0.00184	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—WNT1—osteoporosis	3.17e-06	0.00181	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CALCA—osteoporosis	3.17e-06	0.00181	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—P4HB—osteoporosis	3.12e-06	0.00178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGA—osteoporosis	3.08e-06	0.00176	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TLN1—osteoporosis	3.06e-06	0.00175	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADCY5—osteoporosis	3.04e-06	0.00174	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTH—osteoporosis	3.03e-06	0.00173	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—POMC—osteoporosis	3.02e-06	0.00173	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAP1A—osteoporosis	2.98e-06	0.0017	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CNR2—osteoporosis	2.96e-06	0.00169	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	2.93e-06	0.00168	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFATC1—osteoporosis	2.91e-06	0.00166	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DKK1—osteoporosis	2.88e-06	0.00165	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTHLH—osteoporosis	2.87e-06	0.00164	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—BMP2—osteoporosis	2.87e-06	0.00164	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FDPS—osteoporosis	2.85e-06	0.00163	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PKM—osteoporosis	2.85e-06	0.00163	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGB—osteoporosis	2.8e-06	0.0016	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—WNT1—osteoporosis	2.78e-06	0.00159	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSMA2—osteoporosis	2.71e-06	0.00155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSMA5—osteoporosis	2.71e-06	0.00155	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPD2—osteoporosis	2.7e-06	0.00155	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PGLS—osteoporosis	2.7e-06	0.00155	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGA—osteoporosis	2.7e-06	0.00155	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	2.66e-06	0.00152	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—P4HB—osteoporosis	2.63e-06	0.00151	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTH—osteoporosis	2.56e-06	0.00147	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CALCA—osteoporosis	2.52e-06	0.00144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAP1A—osteoporosis	2.52e-06	0.00144	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTHLH—osteoporosis	2.51e-06	0.00144	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BMP2—osteoporosis	2.51e-06	0.00144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CNR2—osteoporosis	2.5e-06	0.00143	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.48e-06	0.00142	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ATIC—osteoporosis	2.47e-06	0.00141	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PNP—osteoporosis	2.47e-06	0.00141	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—POMC—osteoporosis	2.46e-06	0.00141	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGB—osteoporosis	2.46e-06	0.00141	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFATC1—osteoporosis	2.46e-06	0.0014	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DKK1—osteoporosis	2.44e-06	0.00139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSMA2—osteoporosis	2.37e-06	0.00136	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSMA5—osteoporosis	2.37e-06	0.00136	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—WNT1—osteoporosis	2.35e-06	0.00134	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KL—osteoporosis	2.29e-06	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGA—osteoporosis	2.28e-06	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	2.25e-06	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—POMC—osteoporosis	2.23e-06	0.00128	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CALCA—osteoporosis	2.21e-06	0.00126	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6R—osteoporosis	2.18e-06	0.00125	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—POMC—osteoporosis	2.16e-06	0.00123	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTHLH—osteoporosis	2.12e-06	0.00121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BMP2—osteoporosis	2.12e-06	0.00121	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—OXCT1—osteoporosis	2.1e-06	0.0012	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CA2—osteoporosis	2.1e-06	0.0012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGB—osteoporosis	2.08e-06	0.00119	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MGLL—osteoporosis	2.05e-06	0.00117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KL—osteoporosis	2.01e-06	0.00115	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSMA5—osteoporosis	2.01e-06	0.00115	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSMA2—osteoporosis	2.01e-06	0.00115	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—POMC—osteoporosis	1.98e-06	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.96e-06	0.00112	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.91e-06	0.00109	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.87e-06	0.00107	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PKM—osteoporosis	1.86e-06	0.00107	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FDPS—osteoporosis	1.86e-06	0.00107	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.82e-06	0.00104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.79e-06	0.00103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PGLS—osteoporosis	1.77e-06	0.00101	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPD2—osteoporosis	1.77e-06	0.00101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—IDH2—osteoporosis	1.74e-06	0.000996	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.74e-06	0.000993	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KL—osteoporosis	1.7e-06	0.000971	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.66e-06	0.000947	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.64e-06	0.000937	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ATIC—osteoporosis	1.62e-06	0.000924	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PNP—osteoporosis	1.62e-06	0.000924	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.62e-06	0.000924	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ACP5—osteoporosis	1.59e-06	0.000911	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADCY5—osteoporosis	1.57e-06	0.0009	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS2—osteoporosis	1.57e-06	0.000898	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LEP—osteoporosis	1.54e-06	0.000879	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SPP1—osteoporosis	1.52e-06	0.00087	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TPI1—osteoporosis	1.48e-06	0.000847	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ESR1—osteoporosis	1.47e-06	0.000839	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—P4HB—osteoporosis	1.39e-06	0.000796	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS2—osteoporosis	1.38e-06	0.000787	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CA2—osteoporosis	1.37e-06	0.000786	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.37e-06	0.000786	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS1—osteoporosis	1.37e-06	0.000784	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.37e-06	0.000782	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—osteoporosis	1.35e-06	0.00077	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MGLL—osteoporosis	1.34e-06	0.000766	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.33e-06	0.000761	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.33e-06	0.00076	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—POMC—osteoporosis	1.32e-06	0.000755	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6R—osteoporosis	1.29e-06	0.000736	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SPP1—osteoporosis	1.29e-06	0.000736	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—osteoporosis	1.29e-06	0.000735	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—osteoporosis	1.27e-06	0.000726	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS1—osteoporosis	1.2e-06	0.000687	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.16e-06	0.000665	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—POMC—osteoporosis	1.16e-06	0.000662	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—IDH2—osteoporosis	1.14e-06	0.000651	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—osteoporosis	1.14e-06	0.000651	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6R—osteoporosis	1.13e-06	0.000646	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.11e-06	0.000637	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.09e-06	0.000622	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO1—osteoporosis	1.08e-06	0.000615	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.07e-06	0.000612	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.06e-06	0.000606	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.06e-06	0.000606	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ACP5—osteoporosis	1.04e-06	0.000596	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS1—osteoporosis	1.02e-06	0.000581	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—POMC—osteoporosis	9.78e-07	0.000559	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—osteoporosis	9.71e-07	0.000555	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TPI1—osteoporosis	9.69e-07	0.000554	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6R—osteoporosis	9.54e-07	0.000546	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—osteoporosis	9.41e-07	0.000538	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—P4HB—osteoporosis	9.11e-07	0.000521	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GAPDH—osteoporosis	8.94e-07	0.000511	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RAP1A—osteoporosis	8.71e-07	0.000498	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.61e-07	0.000492	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—osteoporosis	8.51e-07	0.000487	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—osteoporosis	7.63e-07	0.000436	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—osteoporosis	7.61e-07	0.000435	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—osteoporosis	7.2e-07	0.000411	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO1—osteoporosis	7.04e-07	0.000402	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADCY5—osteoporosis	7.03e-07	0.000402	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—osteoporosis	7.01e-07	0.000401	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMA2—osteoporosis	6.94e-07	0.000396	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMA5—osteoporosis	6.94e-07	0.000396	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—osteoporosis	6.69e-07	0.000383	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—osteoporosis	6.67e-07	0.000382	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—osteoporosis	6.47e-07	0.00037	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—osteoporosis	5.74e-07	0.000328	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—osteoporosis	5.65e-07	0.000323	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—osteoporosis	5.64e-07	0.000323	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.63e-07	0.000322	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—POMC—osteoporosis	5.17e-07	0.000296	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—osteoporosis	5.03e-07	0.000288	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADCY5—osteoporosis	4.6e-07	0.000263	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—osteoporosis	4.58e-07	0.000262	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—osteoporosis	4.25e-07	0.000243	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.23e-07	0.000242	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—POMC—osteoporosis	3.38e-07	0.000193	CbGpPWpGaD
